Brain Atrophy and Cognitive Impairment in Chronic Kidney Disease

被引:23
|
作者
Tsuruya, Kazuhiko [1 ,2 ]
Yoshida, Hisako [2 ,3 ]
机构
[1] Nara Med Univ, Dept Nephrol, 840 Shijocho, Kashihara, Nara 6348521, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka, Fukuoka, Japan
[3] Saga Univ Hosp, Clin Res Ctr, Saga, Japan
关键词
HEMODIALYSIS-PATIENTS; PERITONEAL-DIALYSIS; OXYGEN-METABOLISM; ERYTHROPOIETIN; IMPROVEMENT; RISK;
D O I
10.1159/000485694
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: There is an increasing prevalence of dementia associated with population aging, and anti-dementia measures have now become of increasing importance in Japan. Chronic kidney disease (CKD) is a risk factor for cognitive impairment. Summary: We previously demonstrated that hemodialysis patients have a higher prevalence of brain atrophy, even at younger age, than the general population, and also demonstrated the association between frontal lobe atrophy and frequency of rapid decline in blood pressure during the hemodialysis session. Recently, we demonstrated that decline in gray matter volume in CKD patients on peritoneal dialysis was significantly more rapid compared to non-dialysis-dependent CKD patients, and also showed a close association between gray matter atrophy and executive dysfunction in CKD patients, suggesting the importance of preventing brain atrophy for the prevention of cognitive impairment. Our recent epidemiological study demonstrated that both decreased kidney function and albuminuria were identified as independent risk factors for the development of dementia. In addition, it has been reported that possible contributing factors include anemia, oxidative stress, and the renin-angiotensin system (RAS). Previous reports have demonstrated that CKD patients with severe anemia show cognitive impairment, which was recovered by correction of anemia using erythropoiesis-stimulating agents. Then, we examined the role of oxidative stress and RAS using a mouse model of CKD-associated cognitive impairment, and demonstrated that the RAS inhibitor candesartan, as well as the antioxidant tempol, inhibited the development of cognitive impairment through inhibition of oxidative stress in the hippocampus. Key Messages: In CKD patients, progression of brain atrophy is more rapid and cognitive impairment is more common than in non-CKD subjects. Oxidative stress and RAS in the brain are associated with CKD-associated cognitive impairment. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:27 / 36
页数:10
相关论文
共 50 条
  • [31] Animal models to study cognitive impairment of chronic kidney disease
    Silva, Pedro H. Imenez
    Pepin, Marion
    Figurek, Andreja
    Gutierrez-Jimenez, Eugenio
    Bobot, Mickael
    Iervolino, Anna
    Mattace-Raso, Francesco
    Hoorn, Ewout J.
    Bailey, Matthew A.
    Henaut, Lucie
    Nielsen, Rikke
    Frische, Sebastian
    Trepiccione, Francesco
    Hafez, Gaye
    Altunkaynak, Hande O.
    Endlich, Nicole
    Unwin, Robert
    Capasso, Giovambattista
    Pesic, Vesna
    Massy, Ziad
    Wagner, Carsten A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 326 (06) : F894 - F916
  • [32] A new approach for cognitive impairment pattern in chronic kidney disease
    Levassort, Helene
    Boucquemont, Julie
    de Pinho, Natalia Alencar
    Lambert, Oriane
    Helmer, Catherine
    Metzger, Marie
    Teillet, Laurent
    Frimat, Luc
    Combe, Christian
    Fouque, Denis
    Laville, Maurice
    Jacquelinet, Christian
    Liabeuf, Sophie
    Stengel, Benedicte
    Massy, Ziad A.
    Pepin, Marion
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (05) : 848 - 859
  • [33] Factors Affecting Cognitive Impairment in Chronic Kidney Disease Patients
    Pervaiz, Muhammad Shahbaz
    Anees, Muhammad
    Elahi, Irfan
    Butt, Noman
    Tauqer, Saba
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2024, 30 (03): : 289 - 294
  • [34] Comparing regional brain atrophy in mild cognitive impairment and Alzheimer's disease
    Weiler, Marina
    Cendes, Fernando
    Balthazar, Marcio L. F.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (05) : 417 - 426
  • [35] Chronic Kidney Disease and Subclinical Brain Infarction Increase the Risk of Vascular Cognitive Impairment: The Sefuri Study
    Yao, Hiroshi
    Araki, Yuko
    Takashima, Yuki
    Uchino, Akira
    Yuzuriha, Takefumi
    Hashimoto, Manabu
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (02): : 420 - 424
  • [36] STUDY OF BRAIN ATROPHY LINKED WITH COGNITIVE PROCEDURAL LEARNING IMPAIRMENT IN PATIENTS WITH CHRONIC ALCOHOLISM
    Beaunieux, H.
    Pitel, A. L.
    Boudehent, C.
    Lannuzel, C.
    Le Berre, A. P.
    Vabret, F.
    Eustache, F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 234A - 234A
  • [37] Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease
    Burns, Christine M.
    Knopman, David S.
    Tupper, David E.
    Davey, Cynthia S.
    Slinin, Yelena M.
    Lakshminarayan, Kamakshi
    Rossom, Rebecca C.
    Pederson, Sarah L.
    Gilbertson, David T.
    Murray, Anne M.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2018, 73 (03): : 393 - 399
  • [38] Chronic kidney disease and cognitive impairment among the very old in China
    Han Wang
    Chenli Fang
    Lin Cai
    Birong Dong
    Juelin Deng
    Aging Clinical and Experimental Research, 2016, 28 : 475 - 482
  • [39] Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans
    Szerlip, Harold M.
    Edwards, Melissa L.
    Williams, Benjamin J.
    Johnson, Leigh A.
    Vintimilla, Raul M.
    O'Bryant, Sid E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (10) : 2023 - 2028
  • [40] Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease A Review
    Zammit, Andrea R.
    Katz, Mindy J.
    Bitzer, Markus
    Lipton, Richard B.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2016, 30 (04): : 357 - 366